Literature DB >> 1884724

On the differences in psychotropic drug use between the three major urban areas in Sweden.

A Wessling1, U Bergman, B Westerholm.   

Abstract

Marked differences in the utilisation of psychotropic drugs between the three major urban areas in Sweden were recorded from four sources of information: drug supplies from wholesalers to pharmacies, drug supplies to hospitals for in-patient use, drugs sold on prescription for out-patient use, and out-patient consultation and drug prescribing as recorded by physicians. The total sales of psychotropics in the counties of Gothenburg (110.8 defined daily doses per 1000 inhabitants per day) and Malmö (102.1) were much higher than in the county of Stockholm (73.4), with about 25% of the difference being accounted for by diazepam. Differences in the total sales of psychotropics were not explained by any differences in hospital sales, which amounted to about 10% in all counties. Prescription sales differed due to the higher average number of DDD (defined daily doses) per prescription in Gothenburg and Malmö than in Stockholm (total psychotropics 8 and 15%, respectively), and especially because of the higher number of prescriptions per inhabitant (about 40 and 30-35%, respectively). There was no substantial difference in the pattern of diagnoses between areas, but there was a noticeable difference with regard to prescriber category, as psychiatrists accounted for more of the prescriptions in Stockholm than in Gothenburg and Malmö. The results raise questions about over- and under-treatment of mental disorders and about abuse of drugs. In order to explain the geographical differences in psychotropic drug sales morbidity patterns and prescribing practices should be further explored.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1884724     DOI: 10.1007/bf00315229

Source DB:  PubMed          Journal:  Eur J Clin Pharmacol        ISSN: 0031-6970            Impact factor:   2.953


  16 in total

1.  Can regional differences in consumption of tranquillizers and hypnotics be explained by variations in general practitioners' threshold of prescribing? A methodological study.

Authors:  A Bjørndal; P Fugelli
Journal:  Scand J Prim Health Care       Date:  1989-06       Impact factor: 2.581

2.  Patterns of psychotropic drug use in a Swedish community.

Authors:  D Isacson; B Smedby
Journal:  Scand J Prim Health Care       Date:  1988-02       Impact factor: 2.581

Review 3.  Current approaches to measurement of drug use and abuse in Sweden.

Authors:  U Bergman; D Lee
Journal:  NIDA Res Monogr       Date:  1989

4.  Use of computerized databases to survey drug utilization in relation to diagnoses.

Authors:  B L Strom; M L Morse
Journal:  Acta Med Scand Suppl       Date:  1988

5.  Cross-national study of the extent of anti-anxiety-sedative drug use.

Authors:  M B Balter; J Levine; D I Manheimer
Journal:  N Engl J Med       Date:  1974-04-04       Impact factor: 91.245

6.  Utilization of antidiabetic drugs in the Island of Gotland, Sweden: agreement between wholesale figures and prescription data.

Authors:  U Bergman
Journal:  Eur J Clin Pharmacol       Date:  1978-11-27       Impact factor: 2.953

7.  Therapeutic traditions in Northern Ireland, Norway and Sweden: I. Diabetes. WHO Drug Utilization Research Group (DURG).

Authors:  K Griffiths; D G McDevitt; M Andrew; I Baksaas; A Helgeland; J Jervell; P K Lunde; K Oydvin; I Agenäs; U Bergman
Journal:  Eur J Clin Pharmacol       Date:  1986       Impact factor: 2.953

8.  A cross-national comparison of anti-anxiety/sedative drug use.

Authors:  M B Balter; D I Manheimer; G D Mellinger; E H Uhlenhuth
Journal:  Curr Med Res Opin       Date:  1984       Impact factor: 2.580

9.  Relative abuse of diazepam and oxazepam: prescription forgeries and theft/loss reports in Sweden.

Authors:  U Bergman; R R Griffiths
Journal:  Drug Alcohol Depend       Date:  1986-02       Impact factor: 4.492

10.  Continuous recording of drug prescribing in Sweden 1974-1983. Methods and examples of utilization of data.

Authors:  A Wessling
Journal:  Eur J Clin Pharmacol       Date:  1987       Impact factor: 2.953

View more
  9 in total

1.  The use of drugs in Estonia compared to the Nordic countries.

Authors:  R A Kiivet; U Bergman; F Sjöqvist
Journal:  Eur J Clin Pharmacol       Date:  1992       Impact factor: 2.953

2.  Interviewer variability - quality aspects in a case-control study.

Authors:  Kerstin J Blomgren; Anders Sundström; Gunnar Steineck; Bengt-Erik Wiholm
Journal:  Eur J Epidemiol       Date:  2006       Impact factor: 8.082

3.  Anxiolytic-hypnotic drugs: relationships between prescribing, abuse and suicide.

Authors:  A Melander; K Henricson; P Stenberg; P Löwenhielm; J Malmvik; B Sternebring; L Kaij; U Bergdahl
Journal:  Eur J Clin Pharmacol       Date:  1991       Impact factor: 2.953

4.  Antidepressants in suicide: differences in fatality and drug utilisation.

Authors:  J Malmvik; C G Löwenhielm; A Melander
Journal:  Eur J Clin Pharmacol       Date:  1994       Impact factor: 2.953

5.  Benzodiazepine prescribing patterns in a high-prescribing Scandinavian community.

Authors:  A Ekedahl; J Lidbeck; T Lithman; D Noreen; A Melander
Journal:  Eur J Clin Pharmacol       Date:  1993       Impact factor: 2.953

6.  Choice of antidepressants: questionnaire survey of psychiatrists and general practitioners in two areas of Sweden.

Authors:  G Isacsson; I Redfors; D Wasserman; U Bergman
Journal:  BMJ       Date:  1994-12-10

7.  Large intercommunity difference in cardiovascular drug consumption: relation to mortality, risk factors and socioeconomic differences.

Authors:  M Oreberg; G G Jonsson; K West; M Eberhard-Grahn; L Råstam; A Melander
Journal:  Eur J Clin Pharmacol       Date:  1992       Impact factor: 2.953

8.  Age standardisation of drug utilisation: comparisons of different methods using cardiovascular drug data from Sweden and Spain.

Authors:  J Merlo; J Ranstam; L Råstam; A Wessling; A Melander
Journal:  Eur J Clin Pharmacol       Date:  1994       Impact factor: 2.953

9.  Use of antidepressants among people committing suicide in Sweden.

Authors:  G Isacsson; P Holmgren; D Wasserman; U Bergman
Journal:  BMJ       Date:  1994-02-19
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.